Glycopyrrolate Recall: Novadoz Pharmaceuticals Oral Solution
FDA is recalling Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz (473 mL), Rx only. The recall is due to failed impurities/degradation specifications and products distributed nationwide in the United States. Involved lots are CB2505159A, CB2505160A (Exp 04/2027) and CB2505161A (Exp 05/2027); manufactured by MSN Pharmaceuticals Inc. and distributed by Novadoz Pharmaceuticals LLC; NDC 72205-070-72.
| Brand | NOVADOZ PHARMACEUTICALS LLC |
|---|---|
| Product | Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72 |
| Reason | Failed Impurities/Degradation Specifications |
| Severity | low |
| Units affected | N/A |
| Distribution | US Nationwide. |
| Agency | FDA |
WHAT YOU SHOULD DO
- Check your Glycopyrrolate Oral Solution bottles for lot CB2505159A, CB2505160A, or CB2505161A and discard any that are affected.
- Do not use affected product.
- Return the product to the place of purchase or contact your pharmacy for instructions and a replacement if available.
- If you have concerns or symptoms, consult your healthcare provider.
How to identify the recalled item
| Lot / date codes | Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027 |
|---|---|
| Lot / date codes | Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
Other glycopyrrolate recalls
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.